Cargando…
Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a head and neck cancer with poor clinical outcomes and insufficient treatments in Southeast Asian populations. Although concurrent chemoradiotherapy has improved recovery rates of patients, poor overall survival and low efficacy are still critical problems. To impro...
Autores principales: | Chen, Chang-Yu, Lin, Yung-Song, Chen, Chien-Ho, Chen, Yin-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877395/ https://www.ncbi.nlm.nih.gov/pubmed/29598816 http://dx.doi.org/10.1186/s12929-018-0430-8 |
Ejemplares similares
-
Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma
por: Chen, Chang-Yu, et al.
Publicado: (2015) -
Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma
por: Shan, Yunhan, et al.
Publicado: (2022) -
Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma
por: Liao, Li, et al.
Publicado: (2018) -
Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN
por: Chao, Pin-Zhir, et al.
Publicado: (2014) -
Advances in cancer treatment: a new therapeutic target, Annexin A2
por: Li, Zinan, et al.
Publicado: (2021)